LRCX's Gross Margin Near 50%: More Upside Ahead Amid AI-Led Demand?

Lam Research reported Q3 fiscal 2026 revenue of $5.84 billion, up 24% year over year, while non-GAAP EPS rose 41% to a record $1.47 and gross margin improved to 49.9%. Management guided June-quarter gross margin to 50.5% and lifted 2026 wafer fab equipment spending expectations to about $140 billion from $135 billion, supported by AI-driven memory, logic and packaging demand. The stock has already surged 247.3% over the past year, but the article argues margin expansion and earnings growth may continue.

Analysis

LRCX is inflecting from cyclical beneficiary to structural share-taker within the wafer fab equipment stack. The key second-order effect is that AI complexity is expanding the serviceable market for process tools faster than node transitions are normalizing, which should keep pricing power elevated even if unit growth moderates. That said, the real margin upside is likely being driven as much by mix and localization as by outright volume, which means the company can sustain profitability even in a choppier demand tape.

Relative to AMAT and KLAC, LRCX looks best positioned for near-term operating leverage, but KLAC remains the cleaner quality compounder because its >60% gross margin base implies less dependence on a cyclical upturn to defend returns. AMAT is the more dangerous competitor to LRCX over the next 12-24 months because it is increasingly exposed to the same AI packaging and memory pull-through, which can cap LRCX’s share gains even if the end-market stays strong. The likely winner downstream is not hyperscalers, but semiconductor capex suppliers with the most embedded install base and the highest exposure to advanced DRAM and packaging bottlenecks.

The market may be underappreciating the valuation asymmetry: LRCX is already pricing in a fairly clean 2026-2027 earnings trajectory, so the stock now needs estimate revisions to keep working. If WFE spend or AI server digestion slips even modestly, multiple compression could overwhelm incremental margin gains over the next 1-2 quarters. Conversely, a further upward revision to 2027 capex would likely force sell-side upgrades across the group and trigger another leg higher in equipment beta.

The contrarian angle is that the strongest signal here may be not “AI demand is great,” but “equipment supply is still tight enough for suppliers to hold discipline.” If that discipline breaks, margin expansion will flatten quickly despite healthy end-demand. For now, this is a quality-long, but the better expression may be relative value versus names with lower gross margin durability rather than an outright chase at this valuation.

Key Decisions for Investors

• Stay long LRCX for 3-6 months, but use pullbacks to add rather than chase strength; the setup favors continued estimate momentum, though upside is now more dependent on revisions than multiple expansion.
• Pair trade: long LRCX / short AMAT for 1-2 quarters to express higher operating leverage and cleaner margin trajectory in the AI-memory cycle; expect narrower relative performance if packaging demand broadens faster than tools pricing.
• Use KLAC as the defensive long in semicap if risk appetite cools; its higher margin floor makes it the better quality hedge against a digestion-led wobble in WFE sentiment.
• For event risk, buy LRCX call spreads into any pre-earnings pullback over the next 30-60 days; the skew is still favorable if management confirms 2027 capex momentum, but cap upside with a spread given valuation.
• If consensus 2027 WFE estimates stop rising for two consecutive weeks, reduce LRCX exposure by 25-30%; that would be the earliest warning that the trade is transitioning from fundamentals-driven to crowded positioning.